Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00219466 · ClinicalTrials.gov registry record · Phase 4
Clinical Study to Evaluate the Efficacy and Safety of Two Marketed Investigational Products in Children With Diaper Rash
A Phase 4 study, sponsored by Johnson & Johnson Consumer and Personal Products Worldwide.
- Completed
- Registry status
- Phase 4
- Development phase
- 112
- Enrollment target
NCT00219466 is a Phase 4 study that has completed, run by Johnson & Johnson Consumer and Personal Products Worldwide. The registered enrollment target is 112 participants.
The verdict
NCT00219466, a Phase 4 study, has completed, sponsored by Johnson & Johnson Consumer and Personal Products Worldwide.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 112 participants
- Enrollment target
Study Summary
To evaluate whether Desitin; Zinc Oxide Diaper Rash Ointment (Desitin Original) and Desitin Creamy; Zinc Oxide Diaper Rash Ointment (Desitin Creamy) provide relief of the signs and symptoms associated with diaper rash after 12 and 24 hours of product application.
Interventions
- OTHER Zinc Oxide Diaper Rash Ointment
- OTHER Aloe Vera/Tocopherol/Zinc Oxide Cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2005-06 |
| Est. Completion | 2005-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00219466
The ClinicalTrials.gov registry entry for NCT00219466 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Consumer and Personal Products Worldwide, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Zinc Oxide Diaper Rash Ointment is the first listed.
NCT00219466 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00219466 about?
NCT00219466 is a clinical study titled "Clinical Study to Evaluate the Efficacy and Safety of Two Marketed Investigational Products in Children With Diaper Rash". To evaluate whether Desitin; Zinc Oxide Diaper Rash Ointment (Desitin Original) and Desitin Creamy; Zinc Oxide Diaper Rash Ointment (Desitin Creamy) provide relief of the signs and symptoms associated with diaper rash after 12 and 24 hours of product application.
What is the current status of trial NCT00219466?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 112 participants. The study started on 2005-06. Estimated completion is 2005-10.
What interventions are being tested in trial NCT00219466?
The interventions under investigation include: Zinc Oxide Diaper Rash Ointment (OTHER), Aloe Vera/Tocopherol/Zinc Oxide Cream (OTHER).
Who is sponsoring clinical trial NCT00219466?
This trial is sponsored by Johnson & Johnson Consumer and Personal Products Worldwide, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.